Brief: Maravai LifeSciences Outlook FY Revenue USD 275-285 Million
07/11/2023 21:05
Nov 07 (Reuters) - Maravai LifeSciences outlook FY adjusted EPS USD 0.01. * outlook FY adjusted EBITDA USD 55-60 million
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million